Navigation Links
Pharmacyclics Reports Fourth Quarter and Fiscal 2009 Financial Results
Date:9/17/2009

included share-based compensation of $2.3 million.

As of September 1, 2009 the company had approximately $35.0 million in cash and cash equivalents and no long term debt. Additionally, during fiscal 2010 the company has the contracted right to perform research activities and to receive $1.0 million on October 1, 2009 and $1.0 million on April 1, 2010 from Servier and expects to receive $1.3 million in payments for drug shipments in the second half of fiscal 2010.

At June 30, 2009, the company had cash, cash equivalents and marketable securities totaling $16.3 million. This compares to $16.8 million in cash, cash equivalents and marketable securities as of June 30, 2008. Subsequent to June 30, 2009, the company raised, in the recent rights offering, $28.0 million, net of approximately $0.8 million in offering costs. Pharmacyclics' Chairman and CEO, Robert W. Duggan, participated in the offering to the approximate amount of $6.1 million; he was not permitted to oversubscribe. In August of 2009 the company's long term obligation with an affiliate of Robert W. Duggan of $6.4 million was retired.

During fiscal 2009 the company received a $6.4 million loan from an affiliate of its CEO & Chairman, Robert W. Duggan. The loan's stated interest rate was on average 2.5%. Due to the below market interest rate of the loan, the rate had to be adjusted under GAAP to a fair market rate which was accounted for as a loan discount. This discount was amortized to interest expense during fiscal 2009 resulting in non-cash interest expense of approximately $0.3 million in the fourth quarter and approximately $0.5 million for the fiscal year 2009. The accrued interest expense to be paid out, based on the stated rate, for the $6.4 million loan was approximately $0.1 million.

Fiscal 2010 Guidance

With our currently planned clinical trial programs the patient/trial related expenses are expected t
'/>"/>

SOURCE Pharmacyclics
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related medicine news :

1. Pharmacyclics Sets Record Date for Rights Offering
2. Pharmacyclics Reports Third Quarter Fiscal 2009 Financial Results
3. Pharmacyclics Announces Dr. Ahmed Hamdy as New Chief Medical Officer
4. Pharmacyclics Receives Nasdaq Notification
5. Pharmacyclics Files Schedule 14D-9 Statement with Securities and Exchange Commission
6. Pharmacyclics Reports Third Quarter 2008 Financial Results
7. Pharmacyclics Announces Conference Call to Discuss Third Quarter 2008 Financial Results
8. Pharmacyclics Announces Conference Call to Discuss Second Quarter 2008 Financial Results
9. Pharmacyclics Receives Non-Approvable Letter from the FDA for Xcytrin for the Treatment of Lung Cancer Brain Metastases
10. J.D. Power and Associates Reports: Among Pharmacy Customers, Satisfaction is Equally as High for the Privately Insured and for Those With Public-Private Insurance
11. Somanetics Reports Financial Results for the Third Quarter of Fiscal 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/20/2014)... 20, 2014 Earlier this week, Home Depot ... have had their credit card information pilfered by hackers, surpassing ... slew of headline articles like this one published ... eye opening numbers. , “Most people tend to focus ... it’s a way to score a game,” says Joe Caruso, ...
(Date:9/20/2014)... Final Cut Pro X Plugin developers ... Information theme for FCPX filmmakers. , “Fun, cool, and simple ... theme,” says Christina Austin, CEO of Pixel Film Studios. “It ... Information features easy to use controls that give the user ... the background color, color of each circle outline, the position ...
(Date:9/20/2014)... “Motherhood is a wonderful gift and a huge responsibility,” says ... , “We know that you want to care for your ... to do as well.” , The article explains to new ... Family Physicians who practice obstetrics while pregnant, during delivery, and ... learn more about Community Health Center of Snohomish County and ...
(Date:9/19/2014)... (PRWEB) September 20, 2014 Nearly 780 ... of Common Pleas where a meeting took place to ... complaints pending in the court’s mass tort program. ... meet this past week at the Complex Litigation Center ... consolidated for pretrial proceedings. The Risperdal lawsuits filed against ...
(Date:9/19/2014)... (PRWEB) September 19, 2014 Are you ... because of problems with seasonal allergies or sinus congestion? ... much better alternative. , She conceived of Nose ... having a runny nose in public. Since it prevents ... promotes more sanitary conditions, particularly when cooking or working ...
Breaking Medicine News(10 mins):Health News:Don’t Let Data Breach Fatigue Cause Dangerous Cyber Security Complacency 2Health News:Don’t Let Data Breach Fatigue Cause Dangerous Cyber Security Complacency 3Health News:Don’t Let Data Breach Fatigue Cause Dangerous Cyber Security Complacency 4Health News:Don’t Let Data Breach Fatigue Cause Dangerous Cyber Security Complacency 5Health News:Today Pixel Film Studios Announced the Release of the Information Theme for Final Cut Pro X 2Health News:Newest Article from Community Health Center of Snohomish County Highlights The Importance of Proper Health Care for Expectant Mothers 2Health News:Risperdal Lawsuits Move Forward As Attorneys Meet To Discuss Litigation, Reports Wright & Schulte LLC 2Health News:Risperdal Lawsuits Move Forward As Attorneys Meet To Discuss Litigation, Reports Wright & Schulte LLC 3Health News:Risperdal Lawsuits Move Forward As Attorneys Meet To Discuss Litigation, Reports Wright & Schulte LLC 4Health News:Nasal Drip Eliminator Invented by InventHelp Client (LCC-218) 2
... common joint disorder throughout the world and a leading ... mobility, reduction of muscular strength and loss of joint ... about its origins, and factors predicting a severe disease ... first to establish a laboratory marker for the risk ...
... Osteotech Reports Second Quarter 2009 Financial Results , , ... Unveilings in the Third Quarter , , Company ... , Call on July 30, 2009 at 10:00 a.m. EDT ... (Nasdaq: OSTE ), a leader in the emerging field of biologic ...
... , , KING OF PRUSSIA, Pa., ... launch of CompleteView(TM), their much anticipated product for the ... be available to all healthcare segments including life sciences, ... the only full service offering available for complete customer ...
... , WASHINGTON, July 29 The Indoor Tanning Association ... the hype related to the recent categorization of tanning beds as ... Indoor Tanning Association will not stand by and allow some members ... of small business owners who are our members, by grossly exaggerating ...
... , SCHAUMBURG, Ill., July 29 ... Agency for Research on Cancer (IARC) for its re-categorization of ... indoor tanning in the highest cancer risk category afforded by ... Health Organization (WHO). , , "The ...
... , , , ... July 29 Covance (NYSE: CVD ) today ... Inc. relating to the supply of genomic analysis services. Under the terms ... to purchase genomic analysis services from Covance. In addition Covance will acquire ...
Cached Medicine News:Health News:Protein level may serve as predictor of severe osteoarthritis 2Health News:C O R R E C T I O N -- Osteotech, Inc. 2Health News:C O R R E C T I O N -- Osteotech, Inc. 3Health News:C O R R E C T I O N -- Osteotech, Inc. 4Health News:C O R R E C T I O N -- Osteotech, Inc. 5Health News:C O R R E C T I O N -- Osteotech, Inc. 6Health News:C O R R E C T I O N -- Osteotech, Inc. 7Health News:C O R R E C T I O N -- Osteotech, Inc. 8Health News:C O R R E C T I O N -- Osteotech, Inc. 9Health News:Health Market Science Unveils CompleteView, the Most Comprehensive Master Data Management (MDM) Solution Available in the Healthcare Market 2Health News:Health Market Science Unveils CompleteView, the Most Comprehensive Master Data Management (MDM) Solution Available in the Healthcare Market 3Health News:Indoor Tanning Association Fights Back Against Media Hype over Tanning Beds 2Health News:American Academy of Dermatology Commends Reclassification of Tanning Beds as Carcinogenic 2Health News:American Academy of Dermatology Commends Reclassification of Tanning Beds as Carcinogenic 3Health News:Covance to Acquire Seattle-Based Gene Expression Laboratory from Merck & Co., Inc. 2Health News:Covance to Acquire Seattle-Based Gene Expression Laboratory from Merck & Co., Inc. 3
(Date:9/19/2014)... Medical announces the formal launch of the largest ... on the market today at this weekend,s American Orthopaedic ... Chicago .  The Osteotomy Truss System is a comprehensive ... size options included in one versatile set. Previously available ... 18 implant sizes, which limited a surgeon,s ability to ...
(Date:9/19/2014)... NORWALK, Conn. , Sept. 19, 2014 ... , a leading online community to help oncologists ... newest information available regarding the use of targeted therapies ... blood cancer research and treatment.  Every ... as a way to raise awareness about blood cancers—helping ...
(Date:9/19/2014)... Mass. , Sept. 19, 2014  Pressure ... today announced it has received and approved all ... HT48 instruments and has begun to manufacture the ... first instrument will be ready for shipment by ... built and released at a rate of about ...
Breaking Medicine Technology:4WEB Medical Unveils 3D-Printed Osteotomy Truss System 2OncoTherapy Network Highlights National Blood Cancer Awareness Month 2OncoTherapy Network Highlights National Blood Cancer Awareness Month 3OncoTherapy Network Highlights National Blood Cancer Awareness Month 4Pressure BioSciences Announces Completion of the First Phase of Its Commercialization Plan for the Barozyme HT48, the Company's Recently Released High Throughput PCT-based Instrument System 2Pressure BioSciences Announces Completion of the First Phase of Its Commercialization Plan for the Barozyme HT48, the Company's Recently Released High Throughput PCT-based Instrument System 3
... May 20, 2011 /PRNewswire-Asia/ -- Winner Medical Group Inc. ... Company"), a leading manufacturer of medical dressings, medical disposables ... in China, today proudly announced that its PurCotton Industrial ... World of Wipes ("WOW") Innovation Award™. The ...
... 2011 American Regent is conducting a nationwide voluntary recall ... Sterile Water for Injection, USP, 50 mL Single Dose Vial, , ... February, 2014 , ... or Consumer Level, is for Lot 0092 Only. No other lots or sizes of ...
Cached Medicine Technology:Winner Industries (Shenzhen) Nominated for WOW Innovation Award(TM) 2Winner Industries (Shenzhen) Nominated for WOW Innovation Award(TM) 3Winner Industries (Shenzhen) Nominated for WOW Innovation Award(TM) 4American Regent Initiates Nationwide Voluntary Recall of Sterile Water for Injection, USP, 50 mL Single Dose Vial Due to Particulate Matter 2American Regent Initiates Nationwide Voluntary Recall of Sterile Water for Injection, USP, 50 mL Single Dose Vial Due to Particulate Matter 3
... CS Analyzer, designed for Acute Care Diagnostics, is ... and near patient setting. It's a random access ... results from a whole blood sample in as ... process load sample and rotor, load testpak(s) ...
Unique "finger-stick" collection system utilizes a capillary tube for easy blood drawing; no "scooping" necessary. After draining into a microtube, blood is centrifuged and serum or plasma is easily ...
... a small, quiet, high-speed centrifuge. It employs ... which results in nearly vibration- free operation. ... top speed and full breaking in a ... with a simple push-on/ pull-off; transforming the ...
... internal drainage from the ureteropelvic ... sterile in peel-open packages. Intended ... evaluation is advised; polyurethane, C-Flex, ... remain indwelling more than six ...
Medicine Products: